Several patients in the Halton and Durham regions have been diagnosed with Omicron variant of CoVID-19, the vaccine that is being used to protect against hepatitis C virus infection. The vaccine, which targets the normal liver, will also protect against five viruses that cause hepatitis C: CoVID-19, HCV, HCV/O, OIC/C, and FCV.
A U.S. Department of Health and Human Services Advisory Committee is recommending use of the vaccine in adults 25 years of age and older. The vaccine is estimated to offer 94 percent protection against hepatitis C virus infection.
As a result of four positive tests for the Omicron variant, nine cases of the Omicron variant of CoVID-19 were reported in Halton and four cases in Durham, according to a news release from Ministry of Health & Long-Term Care.
“The vaccine has been available for more than 20 years, and the number of cases has remained consistent with previous years,” the Ministry said in the release. “This year, the vaccination has been approved in all three Ontario regions to protect people at risk.”
Omicron variant of CoVID-19 is only approved in Canada.
See below for a list of ways to receive the vaccination. Vaccine doses may be covered by insurance. The information in this release represents advice only from the Ministry of Health & Long-Term Care and may not be definitive due to limitations of the current influenza vaccine supply, including shortage of the vaccine in certain age groups.